Dengue vaccine on anvil
Font size:
NewsByte
Singapore, June 3: A US pharmaceutical firm is working on a vaccine for dengue fever with the potential to neutralise all four strains of the virus that cause the disease, its chief executive said on Tuesday.
Clinical trials of the vaccine will begin in early 2009 in the United States with India and Southeast Asia slated to be the sites for further tests, said Dan Stinchcomb of Inviragen.
"We are focusing on trying to develop a dengue vaccine that can generate very good responses after just one or two doses and we think that this a key to success in this area," he said on the sidelines of the World Vaccine Congress Asia, an industry gathering.
—AFP
del.icio.us
Digg
Technorati
Email to a friend
Print version
Plain text
Comments (0 posted):
Post your comment